openPR Logo
Press release

Human Chorionic Gonadotropin (HCG) Market to Rear Excessive Growth During 2016 – 2024

04-25-2018 04:03 PM CET | Health & Medicine

Press release from: Pharmaceutical Report

Human Chorionic Gonadotropin (HCG) Market to Rear Excessive

Human chorionic gonadotropin hormone (HCG) is a hormone secreted by the placenta after implantation of a fertilized zygote in the uterus. The hormone also supports normal development of an egg and helps in the stimulation of egg release from the ovary. The HCG is mainly used to induce ovulation in the women under infertility treatment. It is also used among males mostly to increase the sperm count and in young boys, due to pituitary gland disorders and other diseases, due to which the testicles of the young males does not drop down naturally into the scrotum. The HCG is usually administered as an injection under the skin into a muscle. The HCG can also be administered at home under the advice of a gynecologist or a pharmacist. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in the determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects.

Rising incidence of infertility are expected to drive the growth of human gonadotropin market across the globe

According to Centers of Disease Control and Prevention (CDC) in 2016, approximately 7.3 million women aged 15 - 44 have used infertility services. Moreover, 6.7% of the married women aged 15 - 44 were reported infertile. According to Azura Vascular Care, around 17% of the couples in the U.S. deal with infertility out of which 30% cases are a result of male infertility. These numbers suggests significant demand for infertility treatments, such as HCG in order for females to conceive a child. According to a statistical survey conducted by HealthGrove, pituitary gland disorders resulted into the death of around 205 people in 2015, out of which highest percentage belonged to white men. Pituitary disorders resulting into significant mortality rate are propelling the demand for human chorionic gonadotropin hormone. Additionally, various other factors such as endometriosis, hormonal imbalance, polycystic ovary syndrome, and others are expected to propel the growth of global HCG market. For instance, according to Frisco Institute of Reproductive Medicine, around 10% of women of reproductive age in the U.S. suffer from polycystic ovary syndrome. However, easy availability of alternatives to treat infertility could act as potential barriers for the market growth.

Get The Holistic SAMPLE With Research Methodology:
https://www.coherentmarketinsights.com/insight/request-sample/1011

Market Taxonomy:

The global human chorionic gonadotropin by Coherent Market Insights is segmented on the basis of Technology, Therapeutic area, and end user.

On the basis of technology, the global human chorionic gonadotropin is segmented as:

Natural Source Extraction
Recombinant DNA Technology
On the basis of therapeutic area, the global human chorionic gonadotropin market is segmented as:

Female infertility treatment
Oligospermic Treatment
Cryptorchidism Treatment
Others
On the basis of end user, the global human chorionic gonadotropin market is segmented as:

Fertility Centers
Research Institutes
Others
North America to dominate global human chorionic gonadotropin (HCG) market, owing to rising frequency of infertility cases

On the basis of geography, the global human chorionic gonadotropin market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is the highest regional contributor to the market and is expected to continue as a regional dominator over the forecast years. This primarily owes to the rising number of infertility cases as well as hormonal dysfunction among young males and females as a result of changing lifestyle. According to Mayo Clinic, around 25% of women fertility problems in the U.S. are a result of ovulation issues that are mostly caused due to dysfunction of human chorionic gonadotropin (HCG) hormone. Thus, the rapidly increasing cases of infertility are expected to surge the North America global human chorionic gonadotropin market. On the other hand, Asia Pacific is anticipated to be the fasting growing geography, owing to economic developments facilitating technological advancements in healthcare sectors as well as emerging local players in the market.

Get Table Of Content:
https://www.coherentmarketinsights.com/ongoing-insight/toc/1011

The key players operating the global human chorionic gonadotropin market include Merck & Co., Inc., EMD Sereno, Inc., Fresenius Kabi, Bristol Myers Squibb Company, Ferring BV, and Kamia Biomedical Company. Acris Antibodies developed a human chorionic gonadotropin hormone by recombinant DNA technology that helps to prevent the disintegration of the corpus luteum of the ovary thereby, maintaining levels of progesterone production for healthy pregnancy in females.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Chorionic Gonadotropin (HCG) Market to Rear Excessive Growth During 2016 – 2024 here

News-ID: 1030581 • Views: 294

More Releases from Pharmaceutical Report

Batten Disease Treatment Market - Global Industry Insights, Trends, Outlook, and …
Batten disease is a rare, inherent, and fatal autosomal recessive neural disorder that begins in the childhood but may take a few years to show symptoms. Batten disease is one of the approximately 50 diseases that fall under the category of lysosome shortage disorders. The batten disease also referred as Neuronal ceroid Lipofuscinoses (NCLs), which is a class of life-limiting genetic neurogenerative diseases that are caused due to abnormality of
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in
Medical Waste Management Market, By Services, and By Techniques - Global Industr …
Healthcare activities generates a lot of waste, especially from the frequently used consumables, which are harmful for in-patients and healthy population. Medical waste includes waste generated within research centers and health-care facilities for example, sharps waste, infectious waste, pathological waste, pharmaceutical waste, chemical waste, and radioactive waste. The waste product that are generated by the healthcare activities have higher potential to spread infection and injuries. Inadequate or incorrect handling of
Insomnia therapeutics Market By Drug Class, and Distribution Channel
Insomnia is a common type of sleep disorder and frequently co-morbid with mental or psychiatric illness. Consistent risk factors for insomnia are age, and stress associated with job, family, financial, and medical conditions. Increase in consumption of alcohol, caffeine, nicotine could also lead to insomnia. Depending on the duration, insomnia is categorized into transient and chronic insomnia. Transient insomnia last for a single night to few weeks or months and

All 5 Releases


More Releases for HCG

Add hCG to a Medical Practice in 2013: Attend the IAPAM's January 25 hCG Trainin …
Las Vegas, Nevada, USA - January 9, 2013 -- In 2012, there was unprecedented positive interest in hCG for weight loss. To meet the ongoing consumer demand for the hCG diet in 2013, the IAPAM is helping physicians enter this lucrative, cash-based market, by offering their NEW and IMPROVED physician-led Clean Start hCG Training in Scottsdale, Arizona on January 25, 2013. Physicians will learn and receive everything they need to
Physicians Certified at the IAPAM's hCG Training are True hCG Experts
Las Vegas, Nevada, USA - June 8, 2012 -- The IAPAM is committed to educating physicians in the industry’s best practices for hCG for weight loss. The scope of the IAPAM's hCG Training ensures that physicians who graduate have unsurpassed clinical and business knowledge on hCG and medical weight management. Attendees receive all the tools needed to launch an hCG diet program, and graduates of the IAPAM's hCG Training are
07-25-2011 | Health & Medicine
IAPAM
Graduates of the IAPAM's hCG Training are True hCG Experts
The IAPAM is committed to educating physicians in the industry’s best practices for hCG for weight loss. The scope of the IAPAM's hCG Training ensures that physicians who graduate have unsurpassed clinical and business knowledge on hCG and medical weight management. Attendees receive all the tools needed to launch an hCG for weight loss program, and graduates of the IAPAM's hCG Training are launching the most successful hCG Clinics in
Graduates of the IAPAM's hCG Training are True hCG Experts
The IAPAM is committed to educating physicians in the industry’s best practices for hCG for weight loss. The scope of the IAPAM's hCG Training ensures that physicians who graduate have unsurpassed clinical and business knowledge on hCG and medical weight management. Attendees receive all the tools needed to launch an hCG for weight loss program, and graduates of the IAPAM's hCG Training are launching the most successful hCG Clinics in
Glenmore Healthcare's hCG Program is Consistent with Dr. Oz's hCG Principles
Calgary, Alberta, June 30, 2011 -- The core principles of Glenmore Healthcare's hCG for Weight Loss Program are consistent with those outlined by Dr. Oz in his interview for First for Women magazine's June 27th issue: it is imperative for patients to undertake an hCG program under the care of a trained physician, and never use hCG (homeopathic hCG) that is sold without a prescription. In his recent interview in the
IAPAM's hCG Directory Helps Consumers Find Expert hCG Physicians
The International Association for Physicians in Aesthetic Medicine offers patients a NEW hCG Diet Clinic listing of physicians in their area, who have been expertly trained in hCG for weight loss by the IAPAM. Las Vegas, NV, May 17, 2011 -- The IAPAM's NEW hCG Diet Listing (http://www.iapam.com/aesthetic-resources/hcg-diet-clinics) provides consumers with a comprehensive listing of qualified IAPAM trained hCG Physicians. Patients seeking out certified physicians, who have completed the IAPAM’s hCG